Stop Taking Nan Bao!

HealthPharmacy
Last updated on
Avatar photo
By Bryan Tan Van Hong

Publicity Associate at YPC. Currently working in Esyms, an online pharmacy platform and Registered Pharmacist at a retail pharmacy. Oh, and not to forget, pun enthusiast.

If you are one of those who consumes ‘Nan Bao’ capsules, be aware that the Health Ministry’s National Pharmaceutical Regulatory Agency (NPRA) has released a statement that all sellers and distributors of this traditional supplement to stop all sales and distribution as it is against the Sale of Drugs Act 1952 and the Control of Drugs and Cosmetics Regulations 1984.

These capsules are found to contain sildenafil and tadalafil, both which are ingredients used medically to treat erectile dysfunction. These medication can only be obtained via a prescription from a doctor. Supplements containing these are not allowed to be classified as traditional.

“The use of sildenafil and tadalafil without a doctor’s advice can cause serious adverse effects such as impairment of vision and hearing, low blood pressure, and effects to the cardiovascular systems such as stroke and heart attack.” The misuse of these medication can prove to be dangerous especially those who consume medication containing nitrates.

If you had tried taking or is currently taking “Nan Bao” supplements, visit your nearest doctor or pharmacist if you experience any discomfort.

Related

Community Pharmacy Logo

Last updated on

This logo was decided recently from a logo competition carried out by the Pharmaceutical Services Division of the Ministry of Health, in collaboration with MPS.  Through a circular from the Pharmacy Enforcement Division of the Ministry of Health dated 30th January it is compulsory to display this logo at all community pharmacy premise. For existing…

This Clinical Pharmacokinetics Pharmacy Handbook 2nd Edition contains the updated information and practice in Clinical Pharmacokinetics Pharmacy. Examples of real case scenario are included in each of the chapter for a better understanding in calculation concept and application. The handbook can be downloaded here.

Stable Coronary Artery Disease (2nd Edition)

Last updated on
The previous clinical practice guidelines for the management of stable angina were issued in 2010. Since then, there have been advances in both diagnostic and therapeutic strategies in the management of this progressive disease. Therefore, it is timely for the publication of this CPG, with a title that is now evolved from stable angina to...

Written by Tang Jia Wen, commitee member of MCPS 2.5   On 27 July 2019, the Malaysian Clinical Pharmacy Symposium (MCPS) 2.5 – A Cancer Therapy Counselling Workshop was held in International Medical University (IMU). It had successfully gathered pharmacists from different backgrounds and provided a conducive platform for them to exchange ideas and thoughts…

At the Malaysian Society of Hypertension’s (MSH) 15th Annual Scientific Meeting, Professor Abdul Rashid Abdul Rahman, the Chairman Working Group on 5th Malaysian Hypertension Clinical Practice Guidelines (CPG) 2018 said that many updates can be expected from the new CPG. One of these new recommendations is the preference for validated electronic blood pressure (BP) sets over mercury sphygmomanometers....

Since our last article on COVID-19, so much has changed-the number of reported cases, better understanding of the virus’ characteristics, and its rebranding to COVID-19. After a harrowing month into the new decade, there’s finally some good news in 2020! This article will cover the rationale behind rebranding, latest statistics, and the roles of pharmacists…

Others

Haze, Don’t Play Play with API

Last updated on

Written by Bryan Tan – Marketing and Communications Associate at YPC, currently a PRP at a retail pharmacy, and pun enthusiast   No, we did not upload the wrong photo. That, my friend, would be your vision if the haze continues to worsen. I’m sure many of you would be coughing or sneezing as you…

A Foreword by Cedric Chua: #ForwardTogether2020

Last updated on

The past decade had been transformative for MPS-YPC. From the relentless championing of young pharmacist issues to the birth of a myriad of initiatives to add value to this group, MPS-YPC had redefined how young pharmacists advocate, connect and develop in an ever changing healthcare industry. Today, fueled by a fast-expanding presence that spreads across…

MPS-YPC 2020/2021 Chairperson Remarks

Last updated on
Another term has ended for the MPS-YPC Committees of 2020/2021. As the curtain falls, here are some words from the outgoing Chairperson, Cedric Chua summarizing the achievements and challenges that his team faced throughout their term.  Dear Fellow Young Pharmacists, The challenges posed by the pandemic in the past two years have spared no one....

We are very honor to be mentioned byInternational Pharmaceutical Federation (FIP)Education report as one of the bodies along with#MPS and Malaysian Pharmacy Students’ Association (MyPSA) in training leadership for pharmacists. We are grateful to all authors for this comprehensive report! We will do our level best in nurturing the next generation of pharmacy leaders. The full report can…

MAP’s e-Learning Portal – Erectile Dysfunction  (CPD Category A8: 3 Points) The aim of this course is to share existing evidence on the diagnosis and management of patients suffering from erectile dysfunction (ED). ED is one of the main growing complaints among males. This course is planned for healthcare providers as a self-study course and…

Sometime in late February, we had the privilege to attend a talk conducted by the co-founder of the Tobacco Free Generation International (TFGI), Dr Koong. Other than ourselves, respected representatives from the Malaysian Women's Action for Tobacco Control and Health (MyWATCH) group such as Dr Samsinar Hussain, Dr Zarihah & Dr Lydia were also present...